www.fdanews.com/articles/126070-first-patients-enrolled-in-cordis-trial-of-stent-graft-system
First Patients Enrolled in Cordis Trial of Stent Graft System
April 9, 2010
Cordis Corporation, a worldwide leader in the development and manufacture
of interventional vascular technologies, announced that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of
a new stent graft system, called INCRAFT, to treat abdominal aortic aneurysm.
GEN
GEN